Table 1.
Laboratory findings of lung cancer patients (Group 1) and control cases (Group 2).
| Group 1 (mean ± SD) | Group 2 (mean ± SD) | p Value | |
|---|---|---|---|
| Age (years) | 58.85 ± 9.26 | 51.82 ± 8.99 | 0.14 |
| Plt, ×10³/μL | 330 ± 104.4 | 233 ± 371.8 | 0.03 * |
| MPV, fL | 7.45 ± 0.80 | 8.79 ± 0.70 | 0.04 * |
| PCT, % | 0.27 ± 0.07 | 0.21 ± 0.04 | 0.03 * |
| PDW, % | 15.19 ± 2.24 | 14.77 ± 1.95 | 0.53 |
| Neutrophile, μL | 6548 ± 3141 | 3595 ± 768 | 0.01 * |
| Lymphocyte, μL | 1928 ± 682 | 2924 ± 811 | 0.02 * |
| NLR | 3.48 ± 0.31 | 0.76 ± 0.08 | 0.0001 * |
| PLR | 105 ± 9.21 | 23.90 ± 3.38 | 0.0001 * |
| WBC, μL | 9500 ± 3428 | 7100 ± 1313 | 0.72 |
| Total protein, g/L | 6.9 ± 0.7 | 7.0 ± 0.4 | 0.17 |
| Albumin, g/L | 3.5 ± 0.5 | 4.0 ± 0.3 | <0.001 * |
| Total Cholesterol, mmol/L | 163.7 ± 31 | 163.9 ± 21.9 | 0.93 |
| Triglyceride, mmol/L | 116.9 ± 42 | 100.9 ± 27.7 | 0.02 * |
| HDL, mmol/L | 34.2 ± 7.7 | 47.7 ± 5.0 | <0.001 * |
| LDL, mmol/L | 104.3 ± 27 | 97.2 ± 20.2 | 0.15 |
| VLDL, mmol/L | 24.7 ± 12.3 | 19.9 ± 7.0 | 0.02 * |
| CRP, mg/L | 12.9 ± 10.9 | 0.45 ± 0.2 | <0.001 * |
* Statistically significant, p < 0.05; SD, standard deviation; WBC, white blood cell; PLT, platelet; PDW, platelet distribution width; MPV, mean platelet volüme; PCT, plateletcrit; CRP, C-reactive protein; HDL, high-density lipoprotein; LDL, low-density lipoprotein; VLDL, very low-density lipoprotein; NLR, neutrophile/lymphocyte ratio; PLR, platelet/lymphocyte ratio.